XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
OPERATING ACTIVITIES    
Net loss $ (3,893,324) $ (5,964,258)
Stock-based compensation-product development costs 1,156,201 1,243,406
Stock-based compensation-general, selling and administration 1,124,395
Stock-based compensation-professional fees 391,843 392,677
Stock-based compensation-interest expense 1,085,371
Non-cash imputed interest expense 92,066 91,867
Accrued interest on line of credit 1,089,110 1,016,122
Changes in assets and liabilities:    
Increase in accounts payable and accrued liabilities 106,169 90,598
Increase in interest payable 396,653 396,652
Net cash used in operating activities (661,282) (523,170)
FINANCING ACTIVITIES    
Proceeds from borrowings on line of credit 648,018 520,388
Proceeds from issuance of shares 12,134
Net cash provided by financing activities 660,152 520,388
Decrease in cash (1,130) (2,782)
Cash, beginning of year 1,838 3,378
Cash, end of year $ 708 $ 596